Lifecore Biomedical, Inc. De (LFCR) Change in Account Payables (2010 - 2025)

Lifecore Biomedical's Change in Account Payables history runs 16 years deep, the most recent figure standing at $1.0 million for Q2 2025.

• In Q2 2025, Change in Account Payables rose 150.7% year-over-year to $1.0 million; the TTM figure through May 2025 stood at -$1.7 million (up 74.99% YoY), while the FY2025 annual figure was -$1.7 million, up 74.99% from the prior year.
• Change in Account Payables was $1.0 million for Q2 2025 at Lifecore Biomedical, up from -$3.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $13.7 million in Q4 2021 to a low of -$12.4 million in Q2 2021.
• Historically, Change in Account Payables has averaged $614055.6 across 5 years, with a median of -$207500.0 in 2023.
• The sharpest annual moves came in 2021 and 2024: Change in Account Payables surged 1592.15% in 2021, then plunged 4708.47% in 2024.
• A 5-year view of Change in Account Payables shows it stood at $13.7 million in 2021, then slipped by 18.67% to $11.1 million in 2022, then tumbled by 100.53% to -$59000.0 in 2023, then slumped by 4708.47% to -$2.8 million in 2024, then jumped by 136.8% to $1.0 million in 2025.
• The last three Change in Account Payables figures came in at $1.0 million (Q2 2025), -$3.5 million (Q1 2025), and -$2.8 million (Q4 2024), per Business Quant data.